LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
1-Year Return
25.93%
This Quarter Return
+9.4%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$704M
AUM Growth
-$442M
(-39%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-69.27%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
402
New
6
Increased
57
Reduced
64
Closed
261
Top Buys
| 1 |
Toll Brothers
TOL
|
$13.4M |
| 2 |
ResMed
RMD
|
$13.2M |
| 3 |
UnitedHealth
UNH
|
$5.08M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$3.65M |
| 5 |
Manulife Financial
MFC
|
$3.33M |
Top Sells
| 1 |
DexCom
DXCM
|
$22.4M |
| 2 |
Insulet
PODD
|
$19M |
| 3 |
Lowe's Companies
LOW
|
$16.2M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$15.8M |
| 5 |
Keysight
KEYS
|
$15.4M |
Sector Composition
| 1 | Healthcare | 32.95% |
| 2 | Consumer Discretionary | 18.04% |
| 3 | Technology | 14.64% |
| 4 | Financials | 13.2% |
| 5 | Industrials | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Aon
AON
$79.9B
| – | – |
-2,336
| Closed | -$737K |
|
277
Apellis Pharmaceuticals
APLS
$3.55B
| – | – |
-71,180
| Closed | -$4.7M |
|
278
Aptiv
APTV
$17.5B
| – | – |
-3,451
| Closed | -$387K |
|
279
Algonquin Power & Utilities
AQN
$4.35B
| – | – |
-22,018
| Closed | -$337K |
|
280
argenx
ARGX
$45.9B
| – | – |
-19,026
| Closed | -$7.09M |
|
281
Array Technologies
ARRY
$1.37B
| – | – |
-48,844
| Closed | -$1.07M |
|
282
Arrowhead Research
ARWR
$4.02B
| – | – |
-98,342
| Closed | -$2.5M |
|
283
AvalonBay Communities
AVB
$27.8B
| – | – |
-2,702
| Closed | -$454K |
|
284
Broadcom
AVGO
$1.58T
| – | – |
-25,480
| Closed | -$1.63M |
|
285
Avery Dennison
AVY
$13.1B
| – | – |
-1,475
| Closed | -$264K |
|
286
AutoZone
AZO
$70.6B
| – | – |
-158
| Closed | -$388K |
|
287
Booz Allen Hamilton
BAH
$12.6B
| – | – |
-7,834
| Closed | -$726K |
|
288
Costco
COST
$427B
| – | – |
-3,075
| Closed | -$1.53M |
|
289
Canadian Pacific Kansas City
CP
$70.3B
| – | – |
-7,367
| Closed | -$1.04M |
|
290
CRISPR Therapeutics
CRSP
$4.99B
| – | – |
-54,786
| Closed | -$2.48M |
|
291
Carlisle Companies
CSL
$16.9B
| – | – |
-1,024
| Closed | -$231K |
|
292
Cintas
CTAS
$82.4B
| – | – |
-2,608
| Closed | -$302K |
|
293
Chevron
CVX
$310B
| – | – |
-11,378
| Closed | -$1.86M |
|
294
GE HealthCare
GEHC
$34.6B
| – | – |
-2,495
| Closed | -$205K |
|
295
Guardant Health
GH
$7.5B
| – | – |
-267,739
| Closed | -$6.28M |
|
296
CGI
GIB
$21.6B
| – | – |
-4,684
| Closed | -$824K |
|
297
Gildan
GIL
$8.27B
| – | – |
-3,325
| Closed | -$202K |
|
298
Glaukos
GKOS
$5.39B
| – | – |
-209,938
| Closed | -$10.5M |
|
299
General Motors
GM
$55.5B
| – | – |
-6,644
| Closed | -$244K |
|
300
Global Payments
GPN
$21.3B
| – | – |
-3,148
| Closed | -$331K |
|